Hee Chan Yoo

1.7k total citations · 2 hit papers
10 papers, 1.1k citations indexed

About

Hee Chan Yoo is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Hee Chan Yoo has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Biochemistry. Recurrent topics in Hee Chan Yoo's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). Hee Chan Yoo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). Hee Chan Yoo collaborates with scholars based in South Korea and United States. Hee Chan Yoo's co-authors include Jung Min Han, Yulseung Sung, Ya Chun Yu, Seung Joon Park, Junjeong Choi, Hee Seung Lee, Seungmin Bang, Geum‐Sook Hwang, Kibum Kim and Jong Soon Kang and has published in prestigious journals such as Nature Communications, Cell Metabolism and Cancer Research.

In The Last Decade

Hee Chan Yoo

8 papers receiving 1.0k citations

Hit Papers

Glutamine reliance in cell metabolism 2019 2026 2021 2023 2020 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hee Chan Yoo South Korea 7 635 545 140 125 116 10 1.1k
Sminu Bose United States 6 849 1.3× 748 1.4× 179 1.3× 142 1.1× 88 0.8× 14 1.2k
Jun‐Kyu Byun South Korea 13 568 0.9× 443 0.8× 143 1.0× 164 1.3× 67 0.6× 25 965
А. Антонов Russia 11 838 1.3× 500 0.9× 230 1.6× 66 0.5× 93 0.8× 54 1.2k
Ahmad A. Cluntun United States 12 964 1.5× 690 1.3× 165 1.2× 179 1.4× 104 0.9× 20 1.5k
Sydney M. Sanderson United States 7 876 1.4× 429 0.8× 142 1.0× 97 0.8× 151 1.3× 7 1.4k
Ibtissam Marchiq France 12 939 1.5× 756 1.4× 198 1.4× 149 1.2× 89 0.8× 16 1.3k
Ya Chun Yu South Korea 5 448 0.7× 354 0.6× 82 0.6× 99 0.8× 57 0.5× 6 782
Ajla Wasti United States 5 1.0k 1.6× 916 1.7× 200 1.4× 140 1.1× 179 1.5× 7 1.6k
Yulseung Sung South Korea 5 448 0.7× 347 0.6× 82 0.6× 98 0.8× 57 0.5× 7 769
Flore Kruiswijk United States 6 1.1k 1.7× 651 1.2× 408 2.9× 117 0.9× 118 1.0× 8 1.6k

Countries citing papers authored by Hee Chan Yoo

Since Specialization
Citations

This map shows the geographic impact of Hee Chan Yoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee Chan Yoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee Chan Yoo more than expected).

Fields of papers citing papers by Hee Chan Yoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hee Chan Yoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee Chan Yoo. The network helps show where Hee Chan Yoo may publish in the future.

Co-authorship network of co-authors of Hee Chan Yoo

This figure shows the co-authorship network connecting the top 25 collaborators of Hee Chan Yoo. A scholar is included among the top collaborators of Hee Chan Yoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hee Chan Yoo. Hee Chan Yoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nguyen, Que Thanh Thanh, Jihye Kim, Hee Chan Yoo, & Eun‐Ju Lee. (2025). Strategies to overcome chemoresistance in epithelial ovarian cancer: Navigating beyond challenges. Critical Reviews in Oncology/Hematology. 210. 104706–104706. 1 indexed citations
2.
Sung, Yulseung, Ya Chun Yu, Mirim Lee, et al.. (2025). Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var. Nature Communications. 16(1). 9690–9690.
3.
Yoo, Hee Chan, et al.. (2025). AAV for ovarian cancer gene therapy. Cancer Gene Therapy. 32(8). 817–830.
4.
Park, Seung Joon, Hee Chan Yoo, Yulseung Sung, et al.. (2023). Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer. Cancer Research. 83(5). 735–752. 34 indexed citations
5.
Yoo, Hee Chan, Byung‐Gyu Kim, Yulseung Sung, et al.. (2022). O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine. Nature Communications. 13(1). 2904–2904. 20 indexed citations
6.
Kim, Jae Hyun, Chulho Lee, Kibum Kim, et al.. (2021). Structure-based modification of pyrazolone derivatives to inhibit mTORC1 by targeting the leucyl-tRNA synthetase-RagD interaction. Bioorganic Chemistry. 112. 104907–104907. 6 indexed citations
7.
Yoo, Hee Chan, Ya Chun Yu, Yulseung Sung, & Jung Min Han. (2020). Glutamine reliance in cell metabolism. Experimental & Molecular Medicine. 52(9). 1496–1516. 655 indexed citations breakdown →
8.
Yoo, Hee Chan, Seung Joon Park, Miso Nam, et al.. (2019). A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. Cell Metabolism. 31(2). 267–283.e12. 312 indexed citations breakdown →
9.
Kim, Eun Young, Jin Gu Lee, Arum Kim, et al.. (2019). Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 11. 3862461838–3862461838. 16 indexed citations
10.
Jung, Young‐Eun, Seungyeop Baek, Sejin Lee, et al.. (2019). Fluorescent 1,4-Naphthoquinones To Visualize Diffuse and Dense-Core Amyloid Plaques in APP/PS1 Transgenic Mouse Brains. ACS Chemical Neuroscience. 10(6). 3031–3044. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026